Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jan;77(1):153-154.
doi: 10.1053/j.ajkd.2020.09.007. Epub 2020 Oct 1.

Favipiravir for COVID-19 in a Patient on Hemodialysis

Daisuke Hirai  1 , Daisuke Yamashita  2 , Koichi Seta  2
Affiliations
Case Reports

Favipiravir for COVID-19 in a Patient on Hemodialysis

Daisuke Hirai et al. Am J Kidney Dis. 2021 Jan.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Blood concentrations of favipiravir. Hemodialysis was performed on days 3, 6, 11, 13, and 17. Abbreviation: PCR, polymerase chain reaction.
See this image and copyright information in PMC

References

    1. Agrawal U., Raju R., Udwadia Z.F. Favipiravir: a new and emerging antiviral option in COVID-19. Med J Armed Forces India. 2020;76(4):370–376. - PMC - PubMed
    1. Irie K., Nakagawa A., Fujita H. Pharmacokinetics of favipiravir in critically ill patients with COVID-19. Clin Transl Sci. 2020;13(5):880–885. - PMC - PubMed
    1. Nguyen T.H., Guedj J., Anglaret X. Favipiravir pharmacokinetics in Ebola-infected patients of the JIKI trial reveals concentrations lower than targeted. PLoS Negl Trop Dis. 2017;11(2) - PMC - PubMed
    1. Wang M., Cao R., Zhang L. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269–271. - PMC - PubMed